🚀 VC round data is live in beta, check it out!
Amorepacific Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Amorepacific Group and similar public comparables like Alicorp, Harbin Fuerjia Technology, SILICON2, Qingdao Baheal Medical and more.
Amorepacific Group Overview
About Amorepacific Group
AmoreG is a manufacturer of personal care products and cosmetics. The company manufactures, markets and trades of cosmetics, personal care goods, and other related products. It also provides skin evaluation services, which measures, dryness, pollutants, and sensitivity of the skin. The company’s products portfolio includes Creams, Toner and Fluids, Ampoule, Cleansing, Eye Care, Serum, Sun Care, Body Care, and Special Care.
Founded
1945
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$1B
Amorepacific Group Financials
Amorepacific Group reported last fiscal year revenue of $3B and EBITDA of $667M.
In the same fiscal year, Amorepacific Group generated $2B in gross profit, $667M in EBITDA, and $170M in net income.
Revenue (LTM)
Amorepacific Group P&L
In the most recent fiscal year, Amorepacific Group reported revenue of $3B and EBITDA of $667M.
Amorepacific Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 72% | XXX | XXX | XXX |
| EBITDA | — | XXX | $667M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 23% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Profit | — | XXX | $170M | XXX | XXX | XXX |
| Net Margin | — | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Amorepacific Group Stock Performance
Amorepacific Group has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Amorepacific Group's stock price is $21.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | (1.3%) | XXX | XXX | XXX | $1.90 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmorepacific Group Valuation Multiples
Amorepacific Group trades at 0.4x EV/Revenue multiple, and 1.6x EV/EBITDA.
EV / Revenue (LTM)
Amorepacific Group Financial Valuation Multiples
As of March 7, 2026, Amorepacific Group has market cap of $2B and EV of $1B.
Equity research analysts estimate Amorepacific Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amorepacific Group has a P/E ratio of 11.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 6.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.5x | XXX | XXX | XXX |
| P/E | — | XXX | 11.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 5.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Amorepacific Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Amorepacific Group Margins & Growth Rates
Amorepacific Group's revenue in the last fiscal year grew by 6%.
Amorepacific Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 57% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 36% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Amorepacific Group Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alicorp | XXX | XXX | XXX | XXX | XXX | XXX |
| Harbin Fuerjia Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| SILICON2 | XXX | XXX | XXX | XXX | XXX | XXX |
| Qingdao Baheal Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Faes Farma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amorepacific Group M&A Activity
Amorepacific Group acquired XXX companies to date.
Last acquisition by Amorepacific Group was on XXXXXXXX, XXXXX. Amorepacific Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Amorepacific Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAmorepacific Group Investment Activity
Amorepacific Group invested in XXX companies to date.
Amorepacific Group made its latest investment on XXXXXXXX, XXXXX. Amorepacific Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Amorepacific Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Amorepacific Group
| When was Amorepacific Group founded? | Amorepacific Group was founded in 1945. |
| Where is Amorepacific Group headquartered? | Amorepacific Group is headquartered in South Korea. |
| Who is the CEO of Amorepacific Group? | Amorepacific Group's CEO is Kyung-Bae Seo. |
| Is Amorepacific Group publicly listed? | Yes, Amorepacific Group is a public company listed on Korea Exchange. |
| What is the stock symbol of Amorepacific Group? | Amorepacific Group trades under 002790 ticker. |
| When did Amorepacific Group go public? | Amorepacific Group went public in 1973. |
| Who are competitors of Amorepacific Group? | Amorepacific Group main competitors are Alicorp, Harbin Fuerjia Technology, SILICON2, Qingdao Baheal Medical. |
| What is the current market cap of Amorepacific Group? | Amorepacific Group's current market cap is $2B. |
| What is the current revenue of Amorepacific Group? | Amorepacific Group's last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Amorepacific Group? | Current revenue multiple of Amorepacific Group is 0.4x. |
| Is Amorepacific Group profitable? | No, Amorepacific Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.